4D pharma to Participate in Jefferies Virtual Next Generation IBD Therapeutics Summit
4D pharma plc (AIM: DDDD, NASDAQ, LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces
Source: finanznachrichten.de